We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
PRFT | Perficient Inc | 74.50 | 26.39 | 54.85% | 22,022 |
ADN | Advent Technologies Holdings Inc | 0.148 | 0.0409 | 38.19% | 49,013 |
NUVO | Holdco Nuvo Group DG Ltd | 2.65 | 0.61 | 29.90% | 529,596 |
OMH | Ohmyhome Ltd | 0.7291 | 0.1651 | 29.27% | 1,121,771 |
ASUR | Asure Software Inc | 9.00 | 1.96 | 27.84% | 1 |
XBP | XBP Europe Holdings Inc | 2.68 | 0.56 | 26.42% | 214,740 |
SEEL | Seelos Therapeutics Inc | 0.42 | 0.0807 | 23.78% | 809 |
DPCS | DP Cap Acquisition Corporation I | 13.81 | 2.62 | 23.42% | 862 |
BENF | Beneficient | 8.41 | 1.59 | 23.31% | 1,150,424 |
BMRA | Biomerica Inc | 0.6787 | 0.1187 | 21.20% | 1 |
CMPX | Compass Therapeutics Inc | 2.04 | 0.34 | 20.00% | 1 |
Perficient, Inc. (Nasdaq: PRFT) (“Perficient”), the leading global digital consultancy transforming the world’s largest enterprises and biggest brands, today reported its financial results for the quarter ended March 31, 2024.
NEW YORK, May 3, 2024 /PRNewswire/ -- S&P MidCap 400 constituent Vistra Corp. (NYSE: VST) will replace Pioneer Natural Resources Co. (NYSE: PXD) in the S&P 500, S&P SmallCap 600 constituent Aaon Inc. (NASD: AAON) will replace Vistra in the S&P MidCap 400, and Marathon Digital Holdings Inc. (NASD: MARA) will replace Aaon in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, May 8. S&P 500 and S&P 100 constituent Exxon Mobil Corp. (NYSE: XOM) acquired Pioneer Natural Resources in a deal that closed today, Friday May 3.
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD), today announced the publication of its TORREY Phase 2 study manuscript in the Lancet Respiratory Medicine journal. The paper, titled "Seralutinib in Adults with Pulmonary Arterial Hypertension (TORREY): A Randomized, Double-blind, Placebo-controlled Phase 2 Trial," details the study's significant findings in advancing the treatment of PAH.
Luna Innovations Incorporated (NASDAQ: LUNA) (“Luna” or the “Company”), a global leader in advanced fiber optic-based technology, today announced two inducement grants pursuant to its 2024 Inducement Plan.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 64,901.03 | 901.95 | 1.41% | 1.28T | 2,670,174,380 |
ETH | Ethereum | 3,188.70 | 52.35 | 1.67% | 384.69B | 1,442,333,806 |
USDT | Tether USD | 1.00 | 0.00 | 0.00% | 97.84B | 138,219,865 |
BNB | Binance Coin | 594.79 | 2.99 | 0.51% | 94.37B | 152,404,686 |
SOL | Solana | 155.18 | 9.53 | 6.54% | 68.96B | 639,956,070 |
STETH | stETH | 3,179.85 | 44.44 | 1.42% | 31.37B | 5,319,117 |
XRP | Ripple | 0.54091 | 0.01122 | 2.12% | 29.61B | 157,291,217 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 414,372,450 |
DOGE | Dogecoin | 0.16453 | 0.00355 | 2.21% | 23.88B | 455,365,014 |
TONCOIN | Wrapped TON Coin | 6.03 | 0.066451 | 1.11% | 21.16B | 93,807,307 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions